These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26376308)

  • 1. Cefepime and Ceftazidime Safety in Hospitalized Infants.
    Arnold CJ; Ericson J; Cho N; Tian J; Wilson S; Chu VH; Hornik CP; Clark RH; Benjamin DK; Smith PB;
    Pediatr Infect Dis J; 2015 Sep; 34(9):964-8. PubMed ID: 26376308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of cefepime and ceftazidime in pediatric oncology patients.
    Hoffman JM; Frediani J; Herr M; Flynn PM; Adderson EE
    Pediatr Blood Cancer; 2013 May; 60(5):806-9. PubMed ID: 23382054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of cefepime: a new extended-spectrum parenteral cephalosporin.
    Neu HC
    Am J Med; 1996 Jun; 100(6A):68S-75S. PubMed ID: 8678100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.
    Schrank JH; Kelly JW; McAllister CK
    Clin Infect Dis; 1995 Jan; 20(1):56-8. PubMed ID: 7727671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants.
    Hornik CP; Herring AH; Benjamin DK; Capparelli EV; Kearns GL; van den Anker J; Cohen-Wolkowiez M; Clark RH; Smith PB;
    Pediatr Infect Dis J; 2013 Jul; 32(7):748-53. PubMed ID: 23838776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ; Palmer D
    Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections.
    Sharifi R; Geckler R; Childs S
    Am J Med; 1996 Jun; 100(6A):76S-82S. PubMed ID: 8678101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
    Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cefepime in late-onset ventilator-associated pneumonia in infants: a pilot randomized and controlled study.
    Shahid SK
    Ann Trop Med Parasitol; 2008 Jan; 102(1):63-71. PubMed ID: 18186979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future management of serious skin and skin-structure infections.
    Schwartz R; Das-Young LR; Ramirez-Ronda C; Frank E
    Am J Med; 1996 Jun; 100(6A):90S-95S. PubMed ID: 8678103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes following hospital-wide implementation of prolonged-infusion cefepime and ceftazidime.
    Turner RB; Slain D; Petros K; Keller LA; Sarwari AR
    Int J Antimicrob Agents; 2015 Jul; 46(1):129-30. PubMed ID: 25957670
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefepime versus ceftazidime for the treatment of serious bacterial infections.
    Ponce-de-León A; López-Meneses M; Sifuentes-Osornio J
    Diagn Microbiol Infect Dis; 1999 Dec; 35(4):263-8. PubMed ID: 10668583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new therapeutic option for the treatment of pneumonia.
    McCabe R; Chirurgi V; Farkas SA; Haddow A; Heinz G; Greene S
    Am J Med; 1996 Jun; 100(6A):60S-67S. PubMed ID: 8678099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.
    Bradley JS; Roilides E; Broadhurst H; Cheng K; Huang LM; MasCasullo V; Newell P; Stone GG; Tawadrous M; Wajsbrot D; Yates K; Gardner A
    Pediatr Infect Dis J; 2019 Sep; 38(9):920-928. PubMed ID: 31335570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
    Hoepelman AI; Kieft H; Aoun M; Kosmidis J; Strand T; Verhoef J; Gillespie SH; Riddell J; Varghese G; Meunier F
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():175-86. PubMed ID: 8150761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective review of neurotoxicity induced by cefepime and ceftazidime.
    Chow KM; Szeto CC; Hui AC; Wong TY; Li PK
    Pharmacotherapy; 2003 Mar; 23(3):369-73. PubMed ID: 12627936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects.
    Gentry LO; Rodriguez-Gomez G
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2371-4. PubMed ID: 1804010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.